My bookmarksSign up free

Commission Regulation (EC) No 349/2009 of 24 April 2009 concerning the classification of certain goods in the Combined Nomenclature

Commission Regulation (EC) No 349/2009 of 24 April 2009 concerning the classification of certain goods in the Combined Nomenclature

Regulation (EC) No 349/2009 · Regulation · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The goods described in column 1 of the table set out in the Annex shall be classified within the Combined Nomenclature under the CN code indicated in column 2 of that table.

Article 2

Binding tariff information issued by the customs authorities of Member States, which is not in accordance with this Regulation, can continue to be invoked for a period of three months under Article 12(6) of Regulation (EEC) No 2913/92.

Article 3

This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX Description of goods Classification (CN Code) Reasons (1) (2) (3) Product in powdered form consisting of (% by weight): — L-Ascorbic acid (vitamin C) 97 — Hydroxypropylmethylcellulose 3 The addition of hydroxypropylmethylcellulose is not necessary for the preservation or transport of vitamin C. The product is suitable for a specific use (manufacture of vitamin tablets) rather than for general use. 2106 90 92 Classification is determined by the General Rules 1 and 6 for the interpretation of the Combined Nomenclature and the wording of CN codes 2106 , 2106 90 and 2106 90 92 . The addition of hydroxypropylmethylcellulose (coating and anti-caking agent) alters the character of the vitamin C product and renders the product technically suitable for the manufacture of vitamin tablets. See also the HS Explanatory Notes to heading 2936 , third paragraph. The product is not intended for therapeutic or prophylactic use, within the meaning of Chapter 30.

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next